Investor Relations

Investors can contact YES INTERNATIONAL, the Company’s investor relations firm at (757)306-6090 regarding information about the publicly trading aspect at BioForce Nanosciences Holdings, Inc. which trades under the stock Symbol BFNH on OTCMARKETS.COM.

Corporate Officers / Directors

Merle Ferguson

Chairman of the Board, CEO, President

Richard Kaiser

Director/ Acting CFO/ Secretary

Trading Symbol: BFNH

US SEC 1934 Act Reporting Issuer: CIK 000131048

Exact title and class of securities outstanding: Common Stock, Par Value $0.001

CUSIP: 09064C107

Par or Stated Value: $0.001

Total shares authorized: 100,000,000               as of: 10/31/2000

Total shares outstanding: 76,305,023                  as of: 11/13/2018

Exact title and class of securities outstanding: Preferred - Class ‘A’

CUSIP: None

Par or Stated Value: $0.001

Total shares authorized:   10,000,000               as of: 01/10/2006

Total shares outstanding: -0-                               as of: 11/13/2018